First household name enters psychedelic sector
Irwin Naturals strikes deal to acquire chain of ketamine treatment clinics in Florida and Mexico
April 18, 2022
Irwin Naturals strikes deal to acquire chain of ketamine treatment clinics in Florida and Mexico
Awakn Provides Shareholders With A Business Update On Its Three Ketamine-Assisted Therapy Clinics In The
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and
Seelos Therapeutics Announces Amendment of SLS-002 Agreement to Repurchase the Remaining Royalties Payable to Phoenixus
Maryland House Gives Initial Approval To Senate-Passed Bill To Fund Psychedelics Research And Access For
Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain TORONTO–(BUSINESS
Delic Expansion Accelerating into 2022 with New Clinic Openings Ketamine Wellness Centers (KWC) Opens Locations
HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-resistant Depression (TRD), Suggesting
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial One in four
Ketamine Wellness Centers (KWC) Expands Treatment Options with Introduction of SPRAVATO® Nasal Spray FDA-Approved Spray
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform Ketamine therapy
Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants Kernel is recruiting participants for a
PharmaTher Announces Positive Topline Results from Clinical Study of Ketamine for Parkinson’s Disease The most
PharmaTher Announces Positive Topline Results from Clinical Study of Ketamine for Parkinson’s Disease 100% of
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
Tasmanian ketamine study to treat chronic pain patients About 60% of patients with chronic pain
M2Bio Labs Offers Ketamine IV & Personalized Supercharged Vitamin IV Drip CAPE TOWN, SA /
Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care The pioneer psychedelic
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study Entheon Biomedical (ENBI) initiated a ketamine
Novamind Advances Clinical Pilot for Frontline KAP nnovative treatment is a candidate to become regular
PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation PharmaTher (PHRM) was granted a US patent
Healing my worth: Sarah’s story Despite having a supportive family and a healthy lifestyle, Sarah
Wellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient KITE Program The